Alembic Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Alembic Pharmaceuticals (APLLTD (Bse Code: 533573)) Key Ratios
Alembic Pharmaceuticals Share Price Analysis Local DB
Alembic Pharmaceuticals share price is ₹826.90, day high (share price) is ₹859.00, day low (share price) is ₹823.25 and volume is 172,875. 52 Week high share price for Alembic Pharmaceuticals is ₹1,002.00 on 20 Aug 2025 and 52 week low share price for Alembic Pharmaceuticals is ₹635.80 on 23 Mar 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Alembic Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 52.1, 50 DMA (50 Displaced Moving Average) is 820.40 and 200 DMA (200 Displaced Moving Average) is 790.39.
Alembic Pharmaceuticals (APLLTD) Technical Analysis
Alembic Pharmaceuticals Technical Data and Analysis available in multiple timeframes.
Alembic Pharmaceuticals Oscillators Analysis
Alembic Pharmaceuticals Price Action
Alembic Pharmaceuticals Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 52.06 |
| Stoch %K (14, 3, 3) | 66.54 |
| CCI (20) | 76.20 |
| ADX (14) | 15.67 |
| Awesome Osc | 8.32 |
| Momentum (10) | 9.40 |
| MACD (12, 26, 9) | 3.55 |
| MACD Signal | 2.99 |
| Stoch RSI (14) | 77.03 |
| Williams %R (14) | -55.39 |
| Bull/Bear Power | 31.76 |
| Ultimate Osc | 45.32 |
| MFI (14) | 54.23 |
| ROC (21) | 2.16 |
| ROC (125) | 16.27 |
| ATR (14) | 22.97 |
Alembic Pharmaceuticals Moving Averages
| Ichimoku Base | 825.78 | Above Base |
| VWMA (20) | 829.23 | Below VWMA |
| HMA (9) | 837.35 | Below HMA |
Alembic Pharmaceuticals Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
- RSI at 52.06 reflects mild positive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Alembic Pharmaceuticals Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 874.92 | 878.45 | 849.98 | 861.38 |
| Resistance 2 | 861.38 | 863.15 | 847.94 | 852.86 |
| Resistance 1 | 852.62 | 856.15 | 845.89 | 847.60 |
| Pivot Point | 839.08 | 840.85 | 843.85 | 839.08 |
| Support 1 | 830.32 | 833.85 | 841.81 | 830.56 |
| Support 2 | 816.78 | 818.55 | 839.76 | 825.30 |
| Support 3 | 808.02 | 811.55 | 837.72 | 816.78 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Alembic Pharmaceuticals - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 69.87% | 69.74% | 69.74% | 69.74% |
| FII | 4.18% | 4.25% | 4.24% | 4.05% |
| DII (Other) | 7.21% | 8.00% | 7.95% | 7.75% |
| Retail & Others | 10.01% | 9.83% | 9.85% | 9.92% |
| Mutual Funds | 8.73% | 8.18% | 8.22% | 8.55% |
Alembic Pharmaceuticals - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 7,399.31 +10.2% | 693.95 -1.87% | 670.83 +15.26% |
| Mar 2025 | 6,714.63 +7.31% | 707.18 +11.93% | 582.01 -5.49% |
| Mar 2024 | 6,256.94 +10.64% | 631.83 +78.19% | 615.82 +80.07% |
| Mar 2023 | 5,655.36 | 354.59 | 341.99 |
Alembic Pharmaceuticals - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 29 Jul 2026 | ₹12 | View Details |
|
Announcement date
15 May 2026
Ex dividend date
29 Jul 2026
Record date
29 Jul 2026
Dividend type
Final
Amount
12.0
Dividend %
600.0
Details
Rs.12.0000 per share(600%)Final Dividend
|
|||
